American International Group, Inc. Karyopharm Therapeutics Inc. Transaction History

American International Group, Inc.

$8.86 Billion
Q2 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$0.72 - $1.66 $344 - $795	-479 Reduced 0.85%	55,816 $84,000
Q4 2023 Feb 13, 2024	SELL	$0.68 - $1.31 $155 - $298	-228 Reduced 0.4%	56,295 $48,000
Q3 2023 Nov 13, 2023	BUY	$1.14 - $1.81 $2,290 - $3,636	2,009 Added 3.69%	56,523 $75,000
Q2 2023 Aug 04, 2023	BUY	$1.79 - $4.59 $30,319 - $77,745	16,938 Added 45.08%	54,514 $97,000
Q1 2023 May 12, 2023	BUY	$2.84 - $3.92 $2,124 - $2,932	748 Added 2.03%	37,576 $146,000
Q4 2022 Feb 10, 2023	BUY	$2.48 - $5.93 $1,629 - $3,896	657 Added 1.82%	36,828 $125,000
Q3 2022 Nov 14, 2022	BUY	$4.08 - $5.82 $2,084 - $2,974	511 Added 1.43%	36,171 $197,000
Q2 2022 Aug 12, 2022	SELL	$4.15 - $8.37 $352 - $711	-85 Reduced 0.24%	35,660 $161,000
Q1 2022 May 13, 2022	SELL	$5.91 - $14.38 $14,875 - $36,194	-2,517 Reduced 6.58%	35,745 $263,000
Q4 2021 Feb 11, 2022	SELL	$5.21 - $8.61 $5,960 - $9,849	-1,144 Reduced 2.9%	38,262 $246,000
Q3 2021 Nov 12, 2021	SELL	$4.45 - $10.63 $4,165 - $9,949	-936 Reduced 2.32%	39,406 $229,000
Q2 2021 Aug 13, 2021	SELL	$8.11 - $11.11 $7,891 - $10,810	-973 Reduced 2.36%	40,342 $416,000
Q1 2021 May 07, 2021	BUY	$9.85 - $17.69 $5,466 - $9,817	555 Added 1.36%	41,315 $435,000
Q4 2020 Feb 12, 2021	SELL	$14.15 - $17.19 $16,541 - $20,095	-1,169 Reduced 2.79%	40,760 $631,000
Q3 2020 Nov 04, 2020	SELL	$14.14 - $19.71 $13,489 - $18,803	-954 Reduced 2.22%	41,929 $612,000
Q2 2020 Aug 12, 2020	BUY	$16.6 - $25.25 $126,342 - $192,177	7,611 Added 21.58%	42,883 $812,000
Q1 2020 May 04, 2020	SELL	$14.38 - $27.72 $29,306 - $56,493	-2,038 Reduced 5.46%	35,272 $678,000
Q4 2019 Feb 05, 2020	BUY	$9.23 - $19.67 $1,910 - $4,071	207 Added 0.56%	37,310 $715,000
Q3 2019 Nov 08, 2019	BUY	$5.66 - $11.85 $2,150 - $4,503	380 Added 1.03%	37,103 $357,000
Q2 2019 Aug 13, 2019	BUY	$4.32 - $6.43 $23,310 - $34,696	5,396 Added 17.22%	36,723 $220,000
Q1 2019 May 06, 2019	SELL	$4.12 - $10.25 $2,426 - $6,037	-589 Reduced 1.85%	31,327 $183,000
Q4 2018 Feb 13, 2019	SELL	$8.2 - $16.95 $2,017 - $4,169	-246 Reduced 0.76%	31,916 $299,000
Q3 2018 Nov 09, 2018	BUY	$17.03 - $21.18 $9,877 - $12,284	580 Added 1.84%	32,162 $548,000
Q2 2018 Aug 08, 2018	BUY	$12.0 - $19.88 $106,428 - $176,315	8,869 Added 39.05%	31,582 $537,000
Q1 2018 May 07, 2018	SELL	$9.92 - $17.25 $525 - $914	-53 Reduced 0.23%	22,713 $305,000
Q4 2017 Feb 09, 2018	BUY	$9.15 - $11.99 $979 - $1,282	107 Added 0.47%	22,766 $219,000
Q3 2017 Nov 09, 2017	BUY	$8.15 - $11.16 $184,670 - $252,874	22,659	22,659 $249,000

Others Institutions Holding KPTI

# of Institutions

120

Shares Held

64.9M

Call Options Held

500K

Put Options Held

99K

Vanguard Group Inc Valley Forge, PA

7.65M
Shares

$6.35 Million
0.0% of portfolio
Palo Alto Investors LP Palo Alto, CA

5.1M
Shares

$4.23 Million
0.56% of portfolio
Eversept Partners, LP New York, NY

4.99M
Shares

$4.14 Million
0.33% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.32M
Shares

$3.59 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.17M
Shares

$3.46 Million
0.0% of portfolio

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $66.2M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account